AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vriglim-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Vriglim-M 1 Tablet PR

DiabetaComb 1 Tablet is an antidiabetic medication, a dual-drug formulation for adult type 2 diabetes management. It effectively regulates blood glucose. Administer DiabetaComb 1 Tablet with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, manifesting as sweating, dizziness, headache, or tremors. Maintain regular meals, carry readily available glucose (e.g., sugary snacks, fruit juice), and avoid alcohol to mitigate this risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your doctor of any prior heart conditions before commencing treatment; pregnancy or breastfeeding necessitates physician consultation. Regular blood glucose monitoring, along with potential blood tests for cell counts and liver function, will be recommended by your doctor.

Uses of Vriglim-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Vriglim-M 1 Tablet PR:

Follow your doctor's instructions or refer to the product label for proper administration. Take one Vriglim-M tablet (PR) with a meal.

Common Side effects of Vriglim-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vriglim-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer one Vriglim-M tablet (PR) with a meal.

How Vriglim-M 1 Tablet PR works:

Vriglim-M PR, a single-tablet formulation, unites the antidiabetic actions of Glimepiride and Metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vriglim-M 1 Tablet PR and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vriglim-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Vriglim-M 1 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vriglim-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Vriglim-M 1 Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Vriglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. Medical advice is necessary. For individuals with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, Vriglim-M 1 Tablet PR is contraindicated in those with severe liver disease.

What if you forget to take Vriglim-M 1 Tablet PR :

Should you forget to take a Vriglim-M 1 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Vriglim-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vriglim-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vriglim-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Vriglim-M 1 Tablet PR and seek immediate medical attention.
Vriglim-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Vriglim-M 1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Vriglim-M 1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Vriglim-M 1 Tablet PR can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Vriglim-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Vriglim-M 1 Tablet PR
86
MRP 99
13% off